AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
![]() You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. ![]() Between 66-89% of retail investor accounts lose money when trading CFDs. Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Shares of Jazz Pharmaceuticals are trading at a forward earnings multiple of 8.8X, as well as a PEG Ratio of 1.1, a Price/Cash Flow ratio of 6.5X, and a Price/Sales ratio of 2.8X. This keeps our service impartial and ad-free. Please open a trading account through our links to tip us. 16 hours ago &0183 &32 On the low end, Axsomes management believes the companys first two commercial-stage products should deliver at least 1.3 billion in peak sales. It does not constitute financial advice.Īffiliate links: This blog is supported by its readers. segmented by top key players including Jazz Pharmaceuticals, Servier Pharmaceuticals. Information published on this website is factual and for information purposes only. V) Stock Price, News, Quote & History - Yahoo Finance Finance Home. is an online publication that covers Forex and CFD providers. For more stocks, head on over to 5 Best Future Stocks for the Long-Term Investing. We do not accept deposits, do not process payments, do not advise on investments, do not deal in investments (as agent or principal) and do not arrange deals in investments. Jazz Pharmaceuticals now sees 2021 revenue of 3.020 bln to 3.180 bln vs. Jat 10:55 AM In this piece, we will take a look at the 13 best future stocks for the long-term. The firms 50 day moving average price is 136.61 and its 200 day moving average price is 145.41. The firm has a market cap of 8.04 billion, a PE ratio of -49.45, a PEG ratio of 0.72 and a beta of 0.74. The company has a debt-to-equity ratio of 1.71, a quick ratio of 2.32 and a current ratio of 3.06. Information published on this website is not directed at residents of the United Arab Emirates or Belgium and is not intended for use by any person in any jurisdiction where such use would be contrary to local law or regulation.ĭisclaimer: is not a Forex or a CFD provider. Shares of JAZZ opened at 125.61 on Tuesday. 12-month price forecasts for Jazz Pharmaceuticals PLC have a median target of 200. It received approval for two new drugs' Zepzelca & Rylaze'. is a trademark of Media Vest FZ-LLC, a company incorporated with the Dubai Development Authority in the United Arab Emirates under registration number 101647. Shares of Avadel Pharmaceuticals (NASDAQ: AVDL) were up as much as 45.5 for the week as of late Friday afternoon, according to data provided by S&P Global. Yahoo Finance - Stock Market Live, Quotes, Business & Finance News. Jazz's oncology portfolio includes two drugs' Defitelio for the treatment hepatic veno-occlusive disease with renal or pulmonary dysfunction following hematopoietic stem cell transplantation & Vyxeos for the treatment of adults with two types of acute myeloid leukemia. & Canada as a treatment for symptom improvement in adult patients with moderate-to-severe spasticity due to multiple sclerosis. Epidiolex is approved for treating seizures associated with two rare & severe forms of epilepsy' Lennox-Gastaut syndrome & Dravet syndrome. Other drugs in the company's neuroscience portfolio include' Sunosi, Epidiolex & Sativex. Both drugs are approved for treating cataplexy & excessive daytime sleepiness in narcolepsy patients. It derives the majority of its revenues from its sleep disorder drugs' Xywav & Xyrem. Jazz Pharmaceuticals is a specialty biopharmaceutical company with a focus in the areas of neuroscience & oncology. ![]() Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and. Jazz Pharmaceuticals Historical Annual Stock Price Data At Yahoo Finance, you get free stock quotes, up-to-date news. ![]()
0 Comments
Read More
Leave a Reply. |